Blood filtration is an essential component in medical practices, especially in surgeries and various therapeutic applications. A primary challenge within this field is the need to effectively capture emboli without inducing additional harm to the patient, such as triggering immune reactions or causing hemolysis. This is where the innovative use of nylon mesh, a product synonymous with the Maishi, comes into play.
Maishi's nylon mesh stand out with their exceptional biocompatibility, proven to be noncytotoxic, non-hemolytic, non-pyrogenic, and non-sensitizing, thereby ensuring safe application in delicate medical scenarios. The precision of these meshes is reflected in their uniform pore sizes. For capturing macroemboli, Maishi provides nylon meshes with a pore size range of 50-200 micrometers, ensuring that larger clots can be sieved without impediment. Moreover, for applications requiring the interception of both macroemboli and microemboli, mesh pore sizes are refined to a range of 1-100 micrometers, with an enhanced focus on the 5-20 micrometer range for optimal filtration of finer particles.
Going further, Maishi offers nylon mesh that extends up to 1000 micrometers (1 mm) to facilitate the filtering of even larger obstructions if required, such as in the treatment of thromboembolic disease. Their adaptability is further evidenced by the combination of different material pore sizes that may be employed to tackle a variety of filtration tasks within the same assembly.
The hydrophilic nature of Maishi's nylon mesh surfaces contributes to high throughput rates, while its non-stick, non-shedding traits deliver unparalleled particle retention efficiency, essential for blood filtration and transfusions.
The robust and reliable nature of Maishi's tailored nylon mesh products ensures that the healthcare industry is well-equipped to manage the complex demands of blood filtration. Welcome to the inquiry MAISHI team to get more technical support.
Tags:
#NylonMeshForBloodFiltration #EmboliCaptureMesh #BiocompatibleNylonMesh
Leave a Comment